Cargando…

Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies

PURPOSE: Side effects and side-effect risk information can be provided using written medicine information. However, challenges exist in effectively communicating this information to consumers. This study aimed to explore broad consumer profiles relevant to ramipril and clopidogrel side-effect risk i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Vivien, Raynor, David K, Blalock, Susan J, Aslani, Parisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501347/
https://www.ncbi.nlm.nih.gov/pubmed/26185427
http://dx.doi.org/10.2147/PPA.S86414
_version_ 1782381055127322624
author Tong, Vivien
Raynor, David K
Blalock, Susan J
Aslani, Parisa
author_facet Tong, Vivien
Raynor, David K
Blalock, Susan J
Aslani, Parisa
author_sort Tong, Vivien
collection PubMed
description PURPOSE: Side effects and side-effect risk information can be provided using written medicine information. However, challenges exist in effectively communicating this information to consumers. This study aimed to explore broad consumer profiles relevant to ramipril and clopidogrel side-effect risk information interpretation. METHODS: Three focus groups were conducted (n=18 consumers) exploring consumer perspectives, understanding and treatment decision making in response to ramipril and clopidogrel written medicine information leaflets containing side effects and side-effect risk information. All discussions were audio recorded, transcribed verbatim, and analyzed to explore consumer profiles pertaining to side-effect risk appraisal. RESULTS: Three consumer profiles emerged: glass half-empty, glass half-full, and middle-of-the-road consumers, highlighting the influence of perceived individual susceptibility, interpretation of side-effect risk information, and interindividual differences, on consumers’ understanding of side-effect risk information. All profiles emphasized the importance of gaining an understanding of individual side-effect risk when taking medicines. CONCLUSION: Written side-effect risk information is not interpreted uniformly by consumers. Consumers formulated their own construct of individual susceptibility to side effects. Health care professionals should consider how consumers interpret side-effect risk information and its impact on medication use. Existing risk communication strategies should be evaluated in light of these profiles to determine their effectiveness in conveying information.
format Online
Article
Text
id pubmed-4501347
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45013472015-07-16 Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies Tong, Vivien Raynor, David K Blalock, Susan J Aslani, Parisa Patient Prefer Adherence Original Research PURPOSE: Side effects and side-effect risk information can be provided using written medicine information. However, challenges exist in effectively communicating this information to consumers. This study aimed to explore broad consumer profiles relevant to ramipril and clopidogrel side-effect risk information interpretation. METHODS: Three focus groups were conducted (n=18 consumers) exploring consumer perspectives, understanding and treatment decision making in response to ramipril and clopidogrel written medicine information leaflets containing side effects and side-effect risk information. All discussions were audio recorded, transcribed verbatim, and analyzed to explore consumer profiles pertaining to side-effect risk appraisal. RESULTS: Three consumer profiles emerged: glass half-empty, glass half-full, and middle-of-the-road consumers, highlighting the influence of perceived individual susceptibility, interpretation of side-effect risk information, and interindividual differences, on consumers’ understanding of side-effect risk information. All profiles emphasized the importance of gaining an understanding of individual side-effect risk when taking medicines. CONCLUSION: Written side-effect risk information is not interpreted uniformly by consumers. Consumers formulated their own construct of individual susceptibility to side effects. Health care professionals should consider how consumers interpret side-effect risk information and its impact on medication use. Existing risk communication strategies should be evaluated in light of these profiles to determine their effectiveness in conveying information. Dove Medical Press 2015-07-09 /pmc/articles/PMC4501347/ /pubmed/26185427 http://dx.doi.org/10.2147/PPA.S86414 Text en © 2015 Tong et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Tong, Vivien
Raynor, David K
Blalock, Susan J
Aslani, Parisa
Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
title Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
title_full Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
title_fullStr Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
title_full_unstemmed Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
title_short Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
title_sort consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501347/
https://www.ncbi.nlm.nih.gov/pubmed/26185427
http://dx.doi.org/10.2147/PPA.S86414
work_keys_str_mv AT tongvivien consumerinterpretationoframiprilandclopidogrelmedicationriskinformationimplicationsforriskcommunicationstrategies
AT raynordavidk consumerinterpretationoframiprilandclopidogrelmedicationriskinformationimplicationsforriskcommunicationstrategies
AT blalocksusanj consumerinterpretationoframiprilandclopidogrelmedicationriskinformationimplicationsforriskcommunicationstrategies
AT aslaniparisa consumerinterpretationoframiprilandclopidogrelmedicationriskinformationimplicationsforriskcommunicationstrategies